Skip to content

Medical device and MedTech insights, news, tips and more

IBM’s Watson Recommended “Unsafe and Incorrect” Cancer Treatments

July 30, 2018

ibm watson

Last year, studies presented at the American Society of Clinical Oncology’s annual meeting showed that IBM Watson was pretty darn good at creating treatment plans for cancer patients. Turns out, however, that the AI is still far from perfect: according to internal documents reviewed by health-oriented news publication Stat, some medical experts working with IBM on its Watson for Oncology system found “multiple examples of unsafe and incorrect treatment recommendations.” In one particular case, a 65-year-old man was diagnosed a drug that could lead to “severe or fatal hemorrhage” even though he was already suffering from severe bleeding.

The report puts the blame on the IBM engineers and the Memorial Sloan Kettering (MSK) Cancer Center doctors who helped train the AI. They reportedly fed Watson hypothetical patients’ data and treatment recommendations by MSK doctors instead of real patients’ information. The approach apparently didn’t work as well as they’d hoped, with one Florida Jupiter Hospital doctor telling IBM upon testing the system that the product is “a piece of shit.” It’s worth noting, however, that MSK believes the example involving the 65-year-old patient was merely part of a system testing and not an actual recommendation.

Despite that Jupiter doctor’s less-than-stellar review, a spokesperson told Gizmodo that the hospital still uses Watson’s recommendations. Its doctors don’t completely rely on the plans it cooks up, though, and see them as an extra opinion when they can’t agree on a treatment. As for IBM, it knows that Watson for Oncology still needs work and has taken feedback from clients into consideration to roll out multiple software updates with updated features over the past year.

Read More at the Source: IBM’s Watson reportedly created unsafe cancer treatment plans

By: Mariella Moon


A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.